pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 18·3 min read
save

U.S. bans entry from Ebola-affected countries as American patient is identified

In response to an Ebola outbreak, the U.S. has banned entry for noncitizens who have been in the Democratic Republic of the Congo, Uganda, or South Sudan recently.

May 18, 2026·read at STAT ↗

Breaking News U.S. bans entry for travelers from Ebola-affected countries The ban, which affects the DRC, Uganda, and South Sudan, is in effect for 30 days for now Manage alerts for this article Email this article Share this article By Annalisa MerelliMay 18, 2026 Contributing Writer Annalisa Merelli[email protected]Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. In response to a fast-moving Ebola outbreak, the Trump administration has imposed a U.S.

entry ban on foreign travelers who have been in the Democratic Republic of the Congo, Uganda, or South Sudan in the past 21 days, according to a new order issued by the Centers for Disease Control and Prevention. The order, aimed at preventing the introduction of Ebola cases into the United States, applies to anyone who was in those countries during in recent weeks, irrespective of their nationality of origin, with the exception of American citizens and members of the army, as well as anyone specifically exempted from the ban by the Department of Homeland Security. Advertisement The order, signed by Jay Bhattacharya, the director of the National Institutes of Health who is also serving as a top CDC official, is in effect for 30 days for now.

This is the first time the U.S. has imposed a travel ban in response to an Ebola outbreak. In the past, officials have relied on a containment strategy that has included enhanced screening of travelers at ports of entry, as was the case during the 2018-2019 Ebola outbreak during President Trump’s first term.

At the time, the CDC coordinated a combination of exit screenings of personnel leaving affected areas and further checks at airports. Advertisement During the West Africa outbreak of 2014-2015, before he was elected, Trump called for a travel ban that would apply to Americans in the affected regions, too, an approach that was later criticized by Tom Price, who Trump selected to be his health secretary and who said letting international health care workers back in the U.S. is “not only our responsibility… it’s a moral action that must be taken.” Cases of Ebola have been reported in the DRC and Uganda, though the order identifies South Sudan as being at risk of spread given its proximity with the affected countries.

Though halting travel from the affected region would reduce the number of high-risk travelers entering the United States, it would not eliminate the risks posed by the presence of these travelers in large transit hubs, the order reads. The virus incubation period is up to 21 days, and potential patients could expose fellow travelers in other global hubs. The order is effective immediately, but it’s been issued with a 30-day comment period to inform future actions.

This is a breaking story and will be updated. Helen Branswell contributed reporting. CDC, infectious diseases, public health Submit a correction requestReprints Annalisa Merelli Contributing Writer Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health.

Newsletter Understand how science, health policy, and medicine shape the world every day Recommended Biotech May 18, 2026 STAT Plus: Supreme Court rejects challenge to Medicare drug price negotiation Exclusive May 17, 2026 In Ebola outbreak, a number of Americans in the Congo believed to have had exposure to suspected cases Advertisement Politics May 15, 2026 STAT Plus: FDA leadership shakeup widens following Makary’s departure Politics May 12, 2026 STAT Plus: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in Politics May 8, 2026 Trump reportedly plans to fire FDA Commissioner Makary Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
594 words · retrieved May 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health

related stories

  • Jun 5STAT+: What stripping civil service protections for thousands of federal workers will mean for HHSSTAT
  • Jun 5Senior NIH official pushes MAHA strategy to skeptical ADA audienceSTAT
  • Jun 5Tiny HHS office tasked with protecting research participants’ safety is running on fumesSTAT
  • Jun 4STAT+: RFK Jr.’s second year: Vacancies, not vaccinesSTAT
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT